Scientific Poster - Prediction of Amyloid PET Status Using the Lumipulse G β Amyloid Ratio (1-42/1-40)

Oct 14, 2022

Background

Cerebrospinal fluid ( amyloid biomarker concentrations are valuable
in the assessment of patients for Alzheimer’s dementia ( Automated platforms and
the additional measurement of Aβ 1 40 (Aβ 40 with Aβ 1 42 (Aβ 42 has decreased
preanalytical variability and increased diagnostic accuracy 1 2 Notably, the ratio
Aβ 42 /Aβ 40 significantly improves concordance with PET when compared to Aβ 42 alone 2
In this study Aβ 42 /Aβ 40 concordance with PET was evaluated on the LUMIPULSE
G 1200 platform

Download the Poster